Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Operating Leases (2016 - 2025)

Historic Operating Leases for AC Immune (ACIU) over the last 10 years, with Q3 2025 value amounting to $4.5 million.

  • AC Immune's Operating Leases rose 6393.22% to $4.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 million, marking a year-over-year increase of 6393.22%. This contributed to the annual value of $5.0 million for FY2024, which is 9984.23% down from last year.
  • As of Q3 2025, AC Immune's Operating Leases stood at $4.5 million, which was up 6393.22% from $4.7 million recorded in Q2 2025.
  • In the past 5 years, AC Immune's Operating Leases registered a high of $3.2 billion during Q4 2023, and its lowest value of $2.0 million during Q3 2022.
  • For the 5-year period, AC Immune's Operating Leases averaged around $639.6 million, with its median value being $3.0 million (2024).
  • In the last 5 years, AC Immune's Operating Leases skyrocketed by 14013259.43% in 2021 and then tumbled by 9990.92% in 2022.
  • Over the past 5 years, AC Immune's Operating Leases (Quarter) stood at $2.5 billion in 2021, then crashed by 99.91% to $2.3 million in 2022, then skyrocketed by 136079.37% to $3.2 billion in 2023, then tumbled by 99.84% to $5.0 million in 2024, then fell by 10.02% to $4.5 million in 2025.
  • Its last three reported values are $4.5 million in Q3 2025, $4.7 million for Q2 2025, and $4.6 million during Q1 2025.